Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2025 Mar 17;17(3):e80702.
doi: 10.7759/cureus.80702. eCollection 2025 Mar.

Persistent Trichomoniasis in Pregnancy: A Case Report Calling for Further Research to Alternative Antibiotic Treatment

Affiliations
Case Reports

Persistent Trichomoniasis in Pregnancy: A Case Report Calling for Further Research to Alternative Antibiotic Treatment

Donya T Sabet et al. Cureus. .

Abstract

Trichomoniasis is an STI caused by a microscopic parasite known as Trichomonas vaginalis. It is considered one of the most widespread nonviral STDs globally. Trichomoniasis during pregnancy can lead to complications such as early rupture of membranes and premature birth. The standard treatment for trichomoniasis in adults, including pregnant individuals, is metronidazole. Recurrent cases may occur due to factors such as incomplete treatment, reinfection, or metronidazole resistance. In cases of persistent trichomoniasis where noncompliance and reinfection have been ruled out, metronidazole resistance should be considered. We present the case of a 39-year-old woman, gravida 4, para 3, with persistent trichomoniasis unresponsive to multiple courses of metronidazole, suggesting potential metronidazole resistance. She experienced recurrent symptoms of threatened preterm labor, likely due to uterine irritability caused by trichomoniasis. While various treatment regimens are available for metronidazole resistance, their safety profiles have not been evaluated during pregnancy. Further research is essential to identify a safe and effective treatment for metronidazole-resistant trichomoniasis in pregnancy.

Keywords: metronidazole resistance; metronidazole-resistant trichomoniasis; persistent trichomoniasis; preterm birth; recurrent trichomoniasis infection; sexually transmitted diseases; threatened preterm labor; trichomonas vaginalis; trichomoniasis; trichomoniasis in pregnancy.

PubMed Disclaimer

Conflict of interest statement

Human subjects: Consent for treatment and open access publication was obtained or waived by all participants in this study. Human Research Ethics Committee issued approval Ex64-24_113921. This project was reviewed by the Human Research Ethics Committee Chair and approved for exemption for ethics approval. It was deemed compliant with the NHMRC guidance “Ethical Consideration in Quality Assurance and Evaluation Activities” 2014. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.

Figures

Figure 1
Figure 1. Tocodynamometer demonstrating uterine contractions
Tocodynamometer demonstrating uterine contractions (blue arrows) detected every two to three minutes.

Similar articles

References

    1. Trichomoniasis. Van Gerwen OT, Opsteen SA, Graves KJ, Muzny CA. Infect Dis Clin North Am. 2023;37:245–265. - PMC - PubMed
    1. The rarity of Trichomonas vaginalis in urban Australia. Bygott JM, Robson JM. Sex Transm Infect. 2013;89:509–513. - PubMed
    1. Trichomoniasis and adverse birth outcomes: a systematic review and meta-analysis. Van Gerwen OT, Craig-Kuhn MC, Jones AT, et al. BJOG. 2021;128:1907–1915. - PMC - PubMed
    1. Trichomoniasis refractory to 5-nitroimidazole therapy in Trinidad. Edwards RJ, Parboo M, Edwards J, Boyce G. Trop Doct. 2023;53:143–145. - PubMed
    1. Treatment of infections caused by metronidazole-resistant Trichomonas vaginalis. Cudmore SL, Delgaty KL, Hayward-McClelland SF, Petrin DP, Garber GE. Clin Microbiol Rev. 2004;17:783-93, table of contents. - PMC - PubMed

Publication types

LinkOut - more resources